Jeff Yass’s Cartesian Therapeutics RNAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$195K Buy
+27,007
New +$235K ﹤0.01% 12002
2025
Q4
– Sell
-12,330
Closed -$100K – 13415
2025
Q3
$126K Buy
12,330
+760
+7% +$8.54K ﹤0.01% 11413
2025
Q2
$120K Sell
11,570
-890
-7% -$9.48K ﹤0.01% 11673
2025
Q1
$164K Buy
+12,460
New +$223K ﹤0.01% 11136
2024
Q2
– Sell
-1,505
Closed -$29.3K – 13049
2024
Q1
$29.3K Sell
1,505
-3,863
-72% -$81.9K ﹤0.01% 11727
2023
Q4
$111K Buy
+5,368
New +$160K ﹤0.01% 11240
2023
Q3
– Sell
-1,198
Closed -$40.2K – 12823
2023
Q2
$40.2K Sell
1,198
-26,838
-96% -$961K ﹤0.01% 11419
2023
Q1
$1.17M Buy
28,036
+27,347
+3,969% +$1.29M ﹤0.01% 6406
2022
Q4
$23.4K Sell
689
-571
-45% -$24.3K ﹤0.01% 11706
2022
Q3
$61K Sell
1,260
-3,294
-72% -$181K ﹤0.01% 12082
2022
Q2
$179K Buy
4,554
+3,305
+265% +$98K ﹤0.01% 10804
2022
Q1
$46K Sell
1,249
-3,642
-74% -$228K ﹤0.01% 12345
2021
Q4
$478K Sell
4,891
-472
-9% -$50.8K ﹤0.01% 9331
2021
Q3
$669K Buy
5,363
+4,020
+299% +$485K ﹤0.01% 8634
2021
Q2
$168K Buy
+1,343
New +$160K ﹤0.01% 11767
2021
Q1
– Sell
-547
Closed -$67.9K – 12757
2020
Q4
$50K Buy
547
+152
+38% +$13.2K ﹤0.01% 10753
2020
Q3
$29K Buy
+395
New +$30.3K ﹤0.01% 10336
2020
Q2
– Sell
-9,621
Closed -$872K – 10791
2020
Q1
$696K Buy
+9,621
New +$929K ﹤0.01% 6208
2019
Q1
– Sell
-423
Closed -$34K – 9687
2018
Q4
$34K Sell
423
-1,508
-78% -$344K ﹤0.01% 8586
2018
Q3
$901K Buy
+1,931
New +$776K ﹤0.01% 5429
2018
Q2
– Sell
-672
Closed -$205K – 10271
2018
Q1
$205K Buy
+672
New +$191K ﹤0.01% 8285
2017
Q2
– Sell
-447
Closed -$192K – 9716
2017
Q1
$192K Buy
+447
New +$188K ﹤0.01% 8034

Other funds holding RNAC

Jeff Yass's RNAC Position: Q3 2026 in Review

Jeff Yass opened a new position in Cartesian Therapeutics (RNAC) in Q3 2026: 27,007 shares worth $195K. The stake represents ﹤0.01% of the portfolio and ranks #12002 among its holdings. This is a return to the name: Jeff Yass previously reported a position in RNAC as recently as Q3 2025.

Jeff Yass first reported a position in RNAC in Q1 2017 and has held it in 22 quarters since. The position peaked at $1.17M in Q1 2023. 95 funds tracked by Wall St. Rank hold RNAC as of Q3 2026.

  • Jeff Yass held 27,007 shares of Cartesian Therapeutics worth $195K as of Q3 2026.
  • Cartesian Therapeutics was a new Jeff Yass position in Q3 2026.
  • Cartesian Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #12002 holding.
  • Jeff Yass first reported a position in Cartesian Therapeutics in Q1 2017 and has held it in 22 quarters since.
  • Jeff Yass's Cartesian Therapeutics position peaked at $1.17M in Q1 2023.
  • 95 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.